Skip to main content

Table 4 Examples of TEG response to different procoagulant states

From: Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk

Procoagulant state

Number of patients in study group

TEG version

Data range in control group,

mean ± SD unless otherwise indicated

Data range in group with hypercoagulation, mean ± SD unless otherwise indicated

Significance

Predictive value

Reference

Comments

Patients with acute ischemic stroke

93-Unfavorable outcome evaluatewd by modified Rankin Scale within a year 91-Favorable outcome

Citrate plasma was mixed with kaolin, and loaded in a heparinise-coated cup

means ± SE MA, mm 63.2 ± 0.5

means ± SE MA, mm 66.1 ± 0.6

<0.001

Prediction of unfavorable outcome At higher tertile of MA OR = 1.192

[92]

Prospective study.

Postoperative Thrombotic Complications

240 patients undergoing a wide variety of surgical procedure s, 10 thrombotic complications

celite-activated TEG on native blood samples within 4 min of collection

MA 66 ± 9

MA 71 ± 9

  

[103]

Prospective study. Thromboelastography was performed immediately after surgery.

6 myocardial infarction

 

MA 66 ± 9

MA 74 ± 5

 

OR = 1.16

Postoperative Thrombotic Complications

152 critically ill patients in the surgical intensive care unit 16 thrombotic complications

native blood, rTEG(activation with kaolin, human recombinant TF, phospholipids)

   

G > 12.4 dynes/cm OR = 1.25

[104]

 

Normal pregnancy

65/65

Recalcified citrate plasma

R, min 7.8 ± 2.5

R, min 6.1 ± 1.8

<0.001

 

[102]

 

K, min 2.7 ± 2.3

K, min 1.4 ± 0.5

Alfa, deg 57.7 ± 11.6

Alfa, deg 70.6 ± 6.5

MA, mm 61 ± 5.9

MA, mm 71 ± 3.8

Ly 30, % 0.8 ± 1.7

Ly 30, % 0.3 ± 0.7